Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=enznLatest Financial News for Enzon Pharmaceuticals, Inc.en-usTue, 22 Dec 2009 22:18:10 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091222/us_enzon_pharma_special_meeting.html?.v=1Enzon Pharmaceuticals Inc. said Tuesday it will hold a shareholder meeting on Jan. 27, 2010, where its stockholders will be able to vote on the sale of most of the company's business.yahoo_finance/3083544400Tue, 22 Dec 2009 22:18:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/xbwsj/rss/SIG=137t5fec9/*http%3A//blogs.wsj.com/financial-adviser/2009/12/22/stocks-that-could-soar-the-last-week-of-the-year/?mod=yahoo_hsyahoo_finance/2522701879Tue, 22 Dec 2009 21:58:36 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091222/20091222005741.html?.v=1BRIDGEWATER, N.J.----Enzon Pharmaceuticals, Inc. announced today that it has set Wednesday, January 27, 2010 as the date of the special meeting of stockholders to vote on the proposed sale of its specialty pharmaceutical business to the sigma-tau Group.yahoo_finance/1900086204Tue, 22 Dec 2009 20:14:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11v7du8th/*http%3A//online.barrons.com/article/SB126118066478397859.html?ru=yahoo&mod=yahoobarrons13D Filingsyahoo_finance/3379148651Sat, 19 Dec 2009 10:49:41 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=1382adiv3/*http%3A//seekingalpha.com/article/178546-baupost-to-purchase-more-facet-biotech-what-about-biogen-idec?source=yahooyahoo_finance/713702232Wed, 16 Dec 2009 22:33:41 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12m4v8640/*http%3A//seekingalpha.com/article/177467-baupost-trims-syneron-stake-buys-more-enzon?source=yahooyahoo_finance/858647902Thu, 10 Dec 2009 08:37:32 Etc/GMThttp://us.rd.yahoo.com/finance/external/investopedia/rss/SIG=13ul0pdoc/*http%3A//stocks.investopedia.com/stock-analysis/2009/Seth-Klarmans-Biggest-Bets-PDLI-NWS-FACT-ENZN-THRX-LINTA-BRK.A1208.aspx?partner=YahooSAyahoo_finance/2440384866Tue, 8 Dec 2009 18:25:32 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh43719_2009-12-03_20-31-05_n03103326_newsml&rpc=44&type=marketsNewsyahoo_finance/2275643328Thu, 3 Dec 2009 20:31:05 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091203/20091203005676.html?.v=1BRIDGEWATER, N.J.----Enzon Pharmaceuticals, Inc. announced today that its Board of Directors has authorized the repurchase of up to $50 million of its outstanding shares of common stock in order to return value to its shareholders.yahoo_finance/1699705305Thu, 3 Dec 2009 14:10:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091119/20091119005618.html?.v=1BRIDGEWATER, N.J.----Enzon Pharmaceuticals, Inc. presented data from its pipeline programs at the 2009 EORTC-NCI-AACR annual meeting in Boston, Massachusetts.yahoo_finance/1992239929Thu, 19 Nov 2009 14:19:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=131c3hnap/*http%3A//seekingalpha.com/article/173926-klarman-whitman-are-sellers-but-witmer-buys-in-q3-2009?source=yahooyahoo_finance/3625065594Wed, 18 Nov 2009 05:55:14 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091116/20091116006600.html?.v=1BRIDGEWATER, N.J.----Enzon Pharmaceuticals, Inc. announced today that data from its pipeline programs will be presented at the 2009 EORTC-NCI-AACR annual meeting being held November 16-19, 2009 in Boston, Massachusetts.yahoo_finance/4047245961Mon, 16 Nov 2009 20:24:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091113/2535_id.html?.v=1Though typically described as a value investor, Seth Klarman's strategy - and his remarkable track record - are difficult to define.yahoo_finance/3730835059Fri, 13 Nov 2009 13:52:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ts/091112/10625844.html?.v=1Baupost's investment in Enzon is a essentially a purchase of future royalty streams.yahoo_finance/2162699063Thu, 12 Nov 2009 20:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091112/enzn8-k.htmlyahoo_finance/1688600519Thu, 12 Nov 2009 13:38:17 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12s1jrh5j/*http%3A//seekingalpha.com/article/172706-baupost-initiates-enzon-position-ups-viasat-stake?source=yahooyahoo_finance/3814810721Wed, 11 Nov 2009 10:03:59 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091110/27125.html?.v=1Shortly after announcing its third quarter results, Enzon announced that it has decided to sell its specialty pharmaceutical business to the Sigma-Tau group of Italy for $300 million.yahoo_finance/2638462411Tue, 10 Nov 2009 20:09:03 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091109/enzn8-k.htmlyahoo_finance/486040627Mon, 9 Nov 2009 19:43:48 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091109/us_enzon_pharma_sale.html?.v=2Enzon Pharmaceuticals Inc. said Monday it is selling most of its business to Italian drugmaker sigma-tau Group and will focus on its experimental cancer drugs and technologies.yahoo_finance/4158775345Mon, 9 Nov 2009 16:18:48 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7b7D971109-DCCD-4EA1-ABDC-4DF540FA5882%7d&siteid=yhoof2yahoo_finance/3632546219Mon, 9 Nov 2009 13:47:00 Etc/GMT